Hsbc Holdings PLC Evelo Biosciences, Inc. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$9.71 - $18.6 $112,568 - $215,629	-11,593 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.91 - $12.28 $55,342 - $173,811	-14,154 Reduced 54.97%	11,593 $140,000
Q1 2020 May 15, 2020	SELL	$3.21 - $7.06 $67 - $148	-21 Reduced 0.08%	25,747 $97,000
Q4 2019 Feb 14, 2020	SELL	$3.81 - $7.45 $98,016 - $191,658	-25,726 Reduced 49.96%	25,768 $106,000
Q3 2019 Nov 14, 2019	BUY	$5.45 - $8.8 $280,642 - $453,147	51,494 New	51,494 $314,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.